![]() PenRad Technologies PenRad Technologies is a company that provides software for breast imaging and lung screening. | ![]() Lunaphore Technologies Lunaphore Technologies is a medtech company, which builds tumor analysis and classification platforms based on microfluidic technology. | ![]() PharmaCCX PharmaCCX (also know as Contingent Commitment Exchange) is a company developing a pricing platform for the oncology drug market. | ![]() eTheRNA eTheRNA immunotherapies is a biotech company developing immuno-oncology therapies based on its APC-activating messenger RNA platform. | ||
Founding Date | Founding Date 2017 | Founding Date 1995 | Founding Date 2014 | Founding Date 2017 | Founding Date 2013 |
Type | Type Private | Type Subsidiary | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Channahon, US HQ Sewickley, US | Locations Buffalo, US HQ | Locations Tolochenaz, CH HQ | Locations Boston, US HQ Stockholm, SE Zug, CH San Mateo, US | Locations Antwerp, BE HQ Ghent, BE Hong Kong, HK Boston, US |
Employees | Employees 1552% increase | Employees 10 | Employees 155 | Employees 558% increase | Employees 1104% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 10m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 2.1m (about 6 years ago) | Latest funding round $ 3m (over 7 years ago) | Latest funding round $ 38.3m (almost 6 years ago) |
Total funding raised | Total funding raised $ 10m | Total funding raised N/A | Total funding raised $ 43.3m | Total funding raised $ 3m | Total funding raised $ 66.3m |

PenRad Technologies is a company that provides software for breast imaging and lung screening.
View company
Lunaphore Technologies is a medtech company, which builds tumor analysis and classification platforms based on microfluidic technology.
View company
PharmaCCX (also know as Contingent Commitment Exchange) is a company developing a pricing platform for the oncology drug market.
View company
eTheRNA immunotherapies is a biotech company developing immuno-oncology therapies based on its APC-activating messenger RNA platform.
View company